A noncoding polymorphism in RAD51, which binds BRCA2 in the DNA repair process, has been shown to increase breast cancer risk in BRCA2 carriers (HR=3.2−5.5) in three independent studies, all performed in AJs (discussed in Simchoni et al, 2006). The gene discussed is BRCA2; the disease is breast carcinoma.